Stephen B. Freedman, PhD, is Vice President for Corporate Liaison and Ventures at the Gladstone Institutes. Through Dr. Freedman's leadership, GCTR has facilitated a number of significant strategic relationships and alliances—across all of Gladstone's research areas—with biotech and pharmaceutical companies, venture capital firms and foundations. GCTR is always looking for new opportunities to advance Gladstone's research through both traditional and non-traditional collaboration models. Dr. Freedman has more than 25 years of experience in the pharmaceutical industry, including senior positions at Merck & Co. and Elan Pharmaceuticals. Dr. Freedman earned a bachelor's degree in physiology and biochemistry and a PhD in pharmacology from the University of Southampton. He received the G. Kerkut Prize for Physiology in 1978 and completed postdoctoral studies with Professor Richard Miller at the University of Chicago.